Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Sanofi patents IL-17A/IL-17RA interaction inhibitors

Dec. 17, 2021

TAXIS Pharmaceuticals divulges bacterial efflux pump inhibitors

Dec. 17, 2021

Sinocelltech describes method for enhancing immunogenicitiy of Fc-fusion antigen

Dec. 16, 2021

Aligos Therapeutics identifies new PD-1/PD-L1 interaction inhibitors

Dec. 16, 2021

Senda Biosciences presents AhR antagonists for cancer

Dec. 16, 2021

G1 Therapeutics discloses new CDK2 inhibitors

Dec. 16, 2021

Kallyope patents AMPK activators

Dec. 16, 2021

Genexine presents fusion proteins for treating immune diseases

Dec. 15, 2021

Chinook Therapeutics identifies LDHA inhibitors

Dec. 15, 2021

Concert Pharmaceuticals presents new JAK inhibitors

Dec. 15, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...